A previous study demonstrated that the loss of ATM did not impact the development of murine AML driven by MLL-AF9 in primary transplants; however, the inhibition of ATM significantly alleviated the disease burden and extended the survival of leukaemia mice [12]. This evidence concerns the gene MLLT3 and acute myeloid leukemia.